<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00545623</url>
  </required_header>
  <id_info>
    <org_study_id>R21AT003377-01</org_study_id>
    <secondary_id>R21AT003377-01</secondary_id>
    <nct_id>NCT00545623</nct_id>
  </id_info>
  <brief_title>Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence</brief_title>
  <official_title>Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of the study are to investigate individual, combined and added effects of
      acupuncture and the relaxation response in reducing gastrointestinal symptoms, improving
      medication adherence and quality of life among people living with HIV/AIDS. The study will
      also explore the mechanism of these therapeutic effects of acupuncture and the relaxation
      response.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in GI Symptom Per Intervention Session</measure>
    <time_frame>8 weeks</time_frame>
    <description>We used the GI symptom subscale of the Revised HIV Sign and Symptom Checklist (SSC-HIV) to measure the intensity (0-10) of the six targeted GI symptoms: diarrhea, loose stools, gas/bloating, abdominal pain, nausea and vomiting, with 0 indicating no symptom and 10 indicating most sever symptom. Rating changes per intervention session were estimated using a mixed effects regression model controlling for baseline ratings. Data of loose stools are presented here.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>ACU+RR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>acupuncture + relaxation response CD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SHAM+RR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sham acupuncture + relaxation response CD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ACU+EDU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>acupuncture+control CD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SHAM+EDU</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham acupuncture+control CD</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks</description>
    <arm_group_label>ACU+RR</arm_group_label>
    <arm_group_label>ACU+EDU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Relaxation Response</intervention_name>
    <description>listening to CDs with verbal instructions of techniques to elicit relaxation response</description>
    <arm_group_label>ACU+RR</arm_group_label>
    <arm_group_label>SHAM+RR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sham acupuncture</intervention_name>
    <description>sham acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks</description>
    <arm_group_label>SHAM+EDU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Confirmed HIV-positive status or AIDS diagnosis

          2. Self report of having at least one of the 6 GI symptoms: diarrhea, loose stools,
             gas/flatulence or bloating, abdominal pain, nausea, or vomiting that have persisted
             for at least 8 weeks.

          3. Being on a stable antiretroviral regimen containing Nucleoside/nucleotide reverse
             transcriptase inhibitors and/or protease inhibitors- for at least 8 weeks.

        Exclusion Criteria:

          1. Incident diagnosis of any of the following conditions within the past month or during
             study period: Pneumocystis carinii pneumonia, Kaposi's sarcoma, Mycobacterium avian
             complex, Cytomegalovirus, Non-Hodgkins lymphoma, Lymphoma or other cancer, Pelvic
             inflammatory disease, AIDS-related dementia, Bacterial or other infection, Diabetes,
             Acute moderate or severe neutropenia, Cryptococcus, Progressive multifocal
             leukoencephalopathy, Idiopathic thrombocytopenic purpura. All of these conditions are
             major opportunistic infections or medical complications that may require
             hospitalization and additional pharmaceutical intervention.

          2. GI diagnoses of irritable bowel syndrome, Crohn's Disease, parasites, any type of
             gastric ulcer or ulcerative colitis or cancer in any part of the gastrointestinal
             system. These are conditions not related to HIV diagnosis and could result in
             digestive problems similar to those we are investigating.

          3. Onset of acute opportunistic infection.

          4. Hemophilia or other bleeding disorder since that will make acupuncture treatment
             unsafe.

          5. Pregnant women will be excluded since, although none of the acupuncture points or
             combinations are contraindicated in pregnancy, the presence of morning sickness could
             serve as a potential confounding factor.

          6. Current users of acupuncture for treating GI symptoms.

          7. Current practice of relaxation response.

          8. Current enrollment in another clinical intervention study.

          9. Cognitive impairment as measured by Mini Mental Status Examination (MMSE), a reliable
             and valid screening instrument for the detection of cognitive impairment, using a
             commonly used cut-off point of 24.

         10. If use of Chinese herbs has been recently discontinued, a potential participant must
             have at least 2 weeks without herb use to be eligible for the study. Because use of
             herbs is occasionally accompanied by digestive disorders,a period of stabilizing is
             required before acupuncture treatment can be initiated. This washout period has been
             conservatively estimated by ACP staff herbalists to constitute a sufficient time for
             effects of herbs to cease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bei-Hung Chang, Sc.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pathways to Wellness</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Chang BH, Sommers E. Acupuncture and the relaxation response for treating gastrointestinal symptoms in HIV patients on highly active antiretroviral therapy. Acupunct Med. 2011 Sep;29(3):180-7. doi: 10.1136/acupmed-2011-010026. Epub 2011 Jun 24.</citation>
    <PMID>21705396</PMID>
  </results_reference>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2007</study_first_submitted>
  <study_first_submitted_qc>October 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2007</study_first_posted>
  <results_first_submitted>July 25, 2014</results_first_submitted>
  <results_first_submitted_qc>August 31, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 3, 2014</results_first_posted>
  <last_update_submitted>August 31, 2014</last_update_submitted>
  <last_update_submitted_qc>August 31, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston University</investigator_affiliation>
    <investigator_full_name>Bei-Hung Chang</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>HIV/AIDS</keyword>
  <keyword>Alternative Medicine</keyword>
  <keyword>Complementary Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ACUP+RR</title>
          <description>acupuncture + relaxation response CD
Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks
Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response</description>
        </group>
        <group group_id="P2">
          <title>SHAM+RR</title>
          <description>sham acupuncture + relaxation response CD
Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response</description>
        </group>
        <group group_id="P3">
          <title>ACUP+EDU</title>
          <description>acupuncture+education CD
Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks</description>
        </group>
        <group group_id="P4">
          <title>SHAM+EDU</title>
          <description>sham acupuncture+education CD
sham acupuncture: sham acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="31"/>
                <participants group_id="P3" count="33"/>
                <participants group_id="P4" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="13"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>A total of 15 patients did not start the intervention after enrollment, 1, 4, 6, and 4 patients in ACUP+RR, SHAM+RR, ACUP+EDU, and SHAM+EDU arms respectively. As such there are a total of 115 patients with baseline data.</population>
      <group_list>
        <group group_id="B1">
          <title>ACUP+RR</title>
          <description>acupuncture + relaxation response CD
Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks
Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response</description>
        </group>
        <group group_id="B2">
          <title>SHAM+RR</title>
          <description>sham acupuncture + relaxation response CD
Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response</description>
        </group>
        <group group_id="B3">
          <title>ACUP+EDU</title>
          <description>acupuncture+education CD
Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks</description>
        </group>
        <group group_id="B4">
          <title>SHAM+EDU</title>
          <description>sham acupuncture+education CD
sham acupuncture: sham acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="31"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="27"/>
            <count group_id="B4" value="30"/>
            <count group_id="B5" value="115"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.2" spread="8.8"/>
                    <measurement group_id="B2" value="45.0" spread="7.1"/>
                    <measurement group_id="B3" value="47.1" spread="9.9"/>
                    <measurement group_id="B4" value="47.0" spread="8.2"/>
                    <measurement group_id="B5" value="46.6" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="21"/>
                    <measurement group_id="B5" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="30"/>
                    <measurement group_id="B5" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Changes in GI Symptom Per Intervention Session</title>
        <description>We used the GI symptom subscale of the Revised HIV Sign and Symptom Checklist (SSC-HIV) to measure the intensity (0-10) of the six targeted GI symptoms: diarrhea, loose stools, gas/bloating, abdominal pain, nausea and vomiting, with 0 indicating no symptom and 10 indicating most sever symptom. Rating changes per intervention session were estimated using a mixed effects regression model controlling for baseline ratings. Data of loose stools are presented here.</description>
        <time_frame>8 weeks</time_frame>
        <population>An intent-to-treat approach was used for analysis. That is all patients who had at least one data points were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>ACUP+RR</title>
            <description>acupuncture + relaxation response CD
Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks
Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response</description>
          </group>
          <group group_id="O2">
            <title>SHAM+RR</title>
            <description>sham acupuncture + relaxation response CD
Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response</description>
          </group>
          <group group_id="O3">
            <title>ACUP+EDU</title>
            <description>acupuncture+education CD
Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks</description>
          </group>
          <group group_id="O4">
            <title>SHAM+EDU</title>
            <description>sham acupuncture+education CD
sham acupuncture: sham acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in GI Symptom Per Intervention Session</title>
          <description>We used the GI symptom subscale of the Revised HIV Sign and Symptom Checklist (SSC-HIV) to measure the intensity (0-10) of the six targeted GI symptoms: diarrhea, loose stools, gas/bloating, abdominal pain, nausea and vomiting, with 0 indicating no symptom and 10 indicating most sever symptom. Rating changes per intervention session were estimated using a mixed effects regression model controlling for baseline ratings. Data of loose stools are presented here.</description>
          <population>An intent-to-treat approach was used for analysis. That is all patients who had at least one data points were included in the analysis.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
                <count group_id="O4" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.24" spread="0.04"/>
                    <measurement group_id="O2" value="-0.08" spread="0.04"/>
                    <measurement group_id="O3" value="-0.09" spread="0.04"/>
                    <measurement group_id="O4" value="-0.09" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>8 week study intervention period and 6 month follow up period</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ACUP+RR</title>
          <description>acupuncture + relaxation response CD
Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks
Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response</description>
        </group>
        <group group_id="E2">
          <title>SHAM+RR</title>
          <description>sham acupuncture + relaxation response CD
Relaxation Response: listening to CDs with verbal instructions of techniques to elicit relaxation response</description>
        </group>
        <group group_id="E3">
          <title>ACUP+EDU</title>
          <description>acupuncture+education CD
Acupuncture: acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks</description>
        </group>
        <group group_id="E4">
          <title>SHAM+EDU</title>
          <description>sham acupuncture+education CD
sham acupuncture: sham acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="31"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="33"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>abnormal but benign tissue in descending colon</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>sever esophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>stomach virus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>thrush</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>car accident</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>broken hip</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>kidney problem</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>cold</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>basal cell CA surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Bei-Hung Chang</name_or_title>
      <organization>Boston University</organization>
      <phone>508-856-8959</phone>
      <email>bhchang@bu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

